Taken together, our findings elucidate a previously unappreciated role of CD153/CD30 signaling in age-dependent TLT formation and might guide the development of novel therapeutic strategies for kidney diseases in the elderly. This evidence concerns the gene TNFRSF8 and kidney disorder.